AzTrials
AzTrials

Overweight and Obese AdultsNCT07183228

Eatit's Obesity Intervention: Effects on Weight, Eating Habits and Health

A study testing Lifestyle Intervention for Obesity in people with Overweight and Obese Adults and Obese Patients (BMI ≥ 30 kg/m²), run by Eatit AB at 1 site in Sweden.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Obesity is a growing public health problem in Sweden, but access to care varies depending on geographical location. Eatit´s multimodal digitally dietitian-supported lifestyle intervention offers an accessible treatment alternative, but its clinical effects in practice need to be documented. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Lifestyle Intervention for Obesity
Could I receive a placebo?
No, everyone receives an active treatment
How many people
93 participants
Where
1 siteSweden
Study dates
3 Sep 2025to 1 Aug 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age 18 years or older
  • Body mass index (BMI) ≥ 30
  • BMI 27-30 in combination with at least one of the following:
  • Has received a diagnosis of obesity from another healthcare provider.
  • Has a comorbidity (according to the defined diagnosis list under the heading Comorbidities below).
  • Has central obesity, defined as waist circumference > 80 cm for women or > 94 cm for men.
Show all 24Show fewer
  • Kostindex score of 4 or lower - eligible for treatment due to increased risk of rapid future weight gain. Dietitian-led intervention may significantly impact weight development in this group.
  • Ability to read and understand Swedish
  • Does not currently use, and does not plan to initiate the use of, appetite-suppressing medication
  • Not pregnant
  • Patients with BMI > 40, As long as there is no contraindication for treatment, treatment is offered. A dietitian may deny the patient the Eatit program if the dietitian assesses that the need for care is too great, and that Eatit's treatment cannot meet the patient's needs.
  • Comorbidities:
  • Cardiovascular disease This is a large group of diagnoses, e.g. previous myocardial infarction or stroke, angina pectoris, heart failure, etc.
  • Hypertension
  • Elevated blood pressure, above 130/85 mmHg or ongoing treatment for previously diagnosed hypertension
  • Hyperlipidemia
  • Triglyceride levels ≥ 1.7 mmol/L or on treatment for elevated triglycerides, or LDL > 3.0 mmol/L at low risk, or on treatment for high cholesterol, or reduced HDL-C <40 mg/dL for men, <50 mg/dL for women, or on treatment for HDL-C
  • Obstructive sleep apnea
  • Type 1 diabetes
  • Type 2 diabetes
  • Prediabetes (fasting glucose ≥ 6.1 or HbA1c > 42 without a diabetes diagnosis)
  • Fatty liver
  • Polycystic ovary syndrome, PCOS
  • Osteoarthritis in the lower body (e.g. hip, knee, or foot)

Who cannot join

  • BMI: Patients with BMI < 27 are excluded from treatment.
  • Medical conditions: Patients with conditions where weight loss or weight gain may worsen the disease are excluded. For example: cancer or chronic obstructive pulmonary disease, COPD.
  • Multimorbidity: Individuals with extensive comorbidities may have complex healthcare needs requiring more comprehensive medical support than Eatit can provide.
  • Untreated depression may hinder participation in the program and should be managed with medical or psychological support.
  • Untreated or ongoing eating disorder (bulimia nervosa, binge eating disorder, anorexia, atypical anorexia, ARFID) should be treated in a specialized eating disorder unit.
  • Severe psychiatric illness (such as psychosis or schizophrenia) without ongoing support.
Show all 16Show fewer
  • Ongoing substance abuse (alcohol, narcotics, or medication) is a contraindication for participation and requires specialized addiction care.
  • Suicidal behavior or self-harm in the past six months. Acute mental illness requires immediate and specialized interventions.
  • Requires individual assessment. Certain conditions require individual evaluation as they may negatively affect treatment outcomes. This means that the treating dietitians should ask follow-up questions to ensure that participation in the program is feasible.
  • Symptoms of binge eating not meeting criteria for binge eating disorder: Ensure that the person is willing to work with the program, not skip meals, and will inform you if the binge eating worsens.
  • Depression under psychiatric care: Ask follow-up questions about what support the person is receiving and his or her current mental state.
  • Bipolar disorder: Ask follow-up questions about what support the person is receiving and his or her current mental state.
  • Exhaustion syndrome/stress: Ask follow-up questions to determine whether treatment is feasible at this time or if the patient needs to manage the stress in other ways first.
  • Neuropsychiatric disorders: To benefit from the program, sufficient concentration ability and capacity for structure/planning in daily life are required. In case of a neuropsychiatric diagnosis, follow-up questions should be asked about whether the person believes that he or she can manage texts and tasks that take approximately 2-3 hours per week.
  • High degree of psychiatric comorbidity has in some studies been shown to be a complicating factor, and this should also be considered at the start of treatment. Ask follow-up questions about what support the person is receiving and his or her current mental state.
  • Severe sleep problems: Sleep deprivation may lead to increased appetite and reduced cognitive capacity, making it difficult to engage with treatment. Ask follow-up questions about possible undiagnosed sleep apnea or potential need for other care to address the sleep problems.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Agnes C Thiel, MSc in Psychology contact

+46 707 46 31 18

agnes@eatitcare.com

Moa Olson, B.Sc.in Dietetics contact

moa@eatitcare.com

Sweden1 site, 1 recruiting
  • Eatit AB

    Stockholm, Stockholm County, 120 30

    Agnes Thiel, MSc in Psychology, +46 707463118, agnes@eatitcare.com

    Agnes C Thiel, MSc in Psychology

    Recruiting

Other trials in Sweden

About this study

Official title: Eatit's Multimodal Digital Lifestyle Intervention for Obesity: A Clinical Pilot Study on Effects on Weight, Self-Rated Eating Habits and Self-Rated Health

Obesity is a growing public health problem in Sweden, but access to care varies depending on geographical location. Eatit´s multimodal digitally dietitian-supported lifestyle intervention offers an accessible treatment alternative, but its clinical effects in practice need to be documented.

The aim of this pilot study is to evaluate the effect of Eatit´s multimodal digitally dietitian-supported lifestyle intervention for weight loss in adults with obesity.

Read more

The main question is:

  • Does body weight change after six months of using the program?

Secondary questions are:

  • Does waist size change after six months of using the program?
  • Do self-rated eating habits improve after six months of using the program?
  • Does self-rated health improve after six months of using the program?

Participants will use the Eatit program for six months and answer questions about their weight, waist size, eating habits and health. The program integrates behavior change techniques with individualized nutrition counseling provided by licensed dietitians.

  • During the first three months, participants use Eatit's core program through the app, with weekly support by a dietitian via video calls and text messages.
  • The core program consists of a weekly reading section combined with a related homework assignment.
  • After completing the core program, participants continue with monthly video sessions with a dietitian, focusing on the skills that were most helpful during the initial phase or on areas such as receiving support to initiate physical activity.
  • Weight and waist size are recorded in the app every week.
  • Questionnaires on eating habits and health are completed at baseline, after three months, and after six months.
Read the detailed description

Study design:

  • Open-label interventional study conducted within Eatit's routine patient flow, where each participant serves as their own control.

Data sources:

  • Data collection to address the research questions regarding treatment effects will be obtained from Eatit's database.

Data to be collected:

-Sex, age, weight, waist circumference, number of completed modules in the digital treatment program, number of completed dietitian visits, as well as results from the self-administered questionnaires Kostindex (Diet Index, developed by the Swedish National Board of Health and Welfare) and World Health Organization Disability Assessment Schedule 2.0, 12-item self-administered version (WHODAS 2.0 12-item).

Recruitment and study participants:

-Five study dietitians will recruit 93 participants through Eatit's routine patient flow. The study population will consist of all eligible individuals who schedule an appointment with a study dietitian, as the aim is to evaluate the treatment effect within Eatit's normal patient population.

Informed consent process:

-The request for study participation is made during Assessment Visit 1, which is conducted by video. If the potential participant expresses interest, the dietitian provides written study information. Inclusion in the study occurs during Assessment Visit 2, after the participant has received both written and verbal information. Participants will be enrolled in the study according to the inclusion criteria, provided that no exclusion criteria are met (see Eligibility). If the participant agrees to take part, informed consent will be obtained digitally.

Intervention:

  • Standard care with Eatit's multimodal digital lifestyle intervention program according to routine practice, delivered over six months with dietitian support via chat and video.

Analysis and statistics:

  • Descriptive statistics will be used to characterize the study population. Treatment effects will be evaluated using appropriate regression and correlation analyses. Subgroup and dropout analyses are planned. Both intention-to-treat (ITT) and per-protocol (PP) approaches will be applied.
Being tested
Lifestyle Intervention for Obesity
Keywords
Obesity, Weight Reduction Programs
Medical subject headings
Overweight, Obesity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Lifestyle Intervention for ObesityBehavioural

    A multimodal obesity lifestyle program delivered via the Eatit app. The dietitian-led intervention consists of 11 structured modules with weekly dietitian support (video consultations and messaging) during the first 11 weeks, followed by monthly video consultations up to six months. The program integrates behavior change techniques with individualized nutrition counseling provided by licensed dietitians.

Study groups in NCT07183228
Study groupRoleWhat they receive
Eatit's Obesity InterventionExperimentalDigital dietitian-led lifestyle Intervention for Obesity.
Receives: Behavioral: Lifestyle Intervention for Obesity

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in body weight (kg)

    Body weight measured in kilograms by participant self-weighing at home. Participants weigh themselves weekly according to standardized instructions (in the morning, after voiding bowels, without clothes, before breakfast) and enter values in the Eatit app.

    Measured: Change from baseline weight to six months.

Secondary outcomes (3)
  1. Change in waist circumference (cm)

    Waist circumference measured in centimeters by participant through self-assessment at home. Participants measure weekly using standardized instructions (measured in the morning after voiding bowels, standing upright, without clothes, tape placed horizontally between the lower rib margin and iliac crest, after exhalation without tightening the tape). Values are entered in the Eatit app.

    Measured: Change from baseline waist circumference to six months.

  2. Change in self-reported eating habits

    Self-reported eating habits assessed with Kostindex (Diet Index, developed by the Swedish National Board of Health and Welfare). Kostindex is a screening tool used to estimate eating habits. Scores range from 0 to 12, with higher scores indicating healthier eating habits. Scoring is divided as follows:

    0-4 points: Unhealthy eating habits

    5-8 points: Less healthy eating habits

    9-12 points: Healthy eating habits

    The questionnaire is self-administered digitally via the Eatit app.

    Measured: Change in Kostindex score from baseline to six months.

  3. Change in self-reported health and disability

    Change in self-reported health and disability, assessed with the World Health Organization Disability Assessment Schedule 12-item version self-administered (WHODAS 12). Each of the 12 items is scored from 0 to 4 (0 = No difficulty, 4 = Extreme difficulty/cannot do), yielding a raw total score ranging from 0 to 48.

    Raw scores are transformed into a value between 0 and 100, expressed as a percentage to indicate degree of disability. Higher scores represent greater disability (worse outcome), with 0% = no disability and 100% = complete disability.

    The questionnaire is self-administered digitally via the Eatit app.

    Measured: Change in WHODAS 2.0 score from baseline to six months.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Sep 2025
  2. Study start3 Sep 2025
  3. Primary completion1 Aug 2026 (estimated)
  4. Study completion1 Aug 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
93 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07183228
Sponsor's protocol ID
2025-04645-01
Other IDs
2025
Status last verified
Sep 2025
First submitted
9 Sep 2025
Last updated
19 Sep 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Lifestyle Intervention for Obesity in people with Overweight and Obese Adults and Obese Patients (BMI ≥ 30 kg/m²), run by Eatit AB at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 24 inclusion and 16 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 19 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Agnes C Thiel, MSc in Psychology (+46 707 46 31 18, agnes@eatitcare.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in body weight (kg) (time frame: Change from baseline weight to six months.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Sep 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in